期刊文献+

低凝血酶原血症-狼疮抗凝物综合征:1例报道并文献复习 被引量:9

Hypoprothrombinemia-Lupus Anticoagulant Syndrome:A Case Report and Review of Literature
下载PDF
导出
摘要 目的探讨低凝血酶原血症-狼疮抗凝物综合征(HLAS)的病因、临床表现、诊断和治疗。方法回顾性分析我院确诊的1例伴出血时间延长的HLAS患者的临床特点,并结合文献报道加以归纳总结。结果HLAS临床表现差异很大,与体内凝血酶原活性不完全平行。年轻患者病因以结缔组织病和病毒感染为主,前者激素治疗通常有效,少数需要加用免疫抑制剂或静脉注射用免疫球蛋白(IVIG);后者主要发生在儿童,通常在3个月内自发缓解,个别患者需要使用激素治疗。年长者常见病因为肿瘤、药物相关或原因不明。结论对于不明原因的出血患者,应警惕HLAS的可能。 Objective To explore the etiology, diagnosis and treatment of hypoprothrombinemia-lupus anticoagulant syndrome (HLAS). Methods The clinical characteristics and laboratory results of 1 case of HLAS with prolonged bleeding time was analyzed, and the literature was reviewed. Results The clinical manifestation of HLAS varies, from asymptomatic to severe hemorrhage. HLAS was strongly associated with autoimmune diseases in young adults, and glucocorticoids were effective in majority, immunosuppressor or intravenous immunoglobulin (WIG) was also needed in few cases. Virus associated HLAS was mostly found in children, and can be self-limited, and spontaneous remission within 3 months, few needed glucocoricoids. The main causes of HLAS in adults were tumor, drug related or unknown. Conclusion HLAS is rare. Cases of HLAS should be thoroughly investigated for any known causes and related disorders.
出处 《血栓与止血学》 2010年第2期82-85,91,共5页 Chinese Journal of Thrombosis and Hemostasis
关键词 狼疮抗凝物 低凝血酶原血症 出血时间 Lupus anticoagulant Hypoprothrombinemia Bleeding time
  • 相关文献

参考文献9

  • 1GIANNAKOPOULOS B, PASSAM F, RAHGOZAR S, et al. Current concepts on the pathogenesis of the antiphospholipid syndrome [ J ]. Blood ,2007,109:422-430.
  • 2VIVALDI P, ROSSETTI G, GALLI M, et al. Severe bleeding due to acquired hypoprothrombinemialupus anticoagulant syndrome. Case report and review of literature [ J]. Haematologica, 1997, 82 : 345- 347.
  • 3RAPAPORT SI, AMES SB, DUVALL BJ. A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with anti-prothrombinase activity [ J ]. Blood, 1960,15:212-227.
  • 4FLECK R, RAPAPORT SI, RAO LV. Anti-prothrombin antibodies and the Lupus anticoagulant[ J]. Blood , 1988, 72:512-519.
  • 5MALE C, LECHNER K, EICHINGER S, et al. Clinical significance of lupus anticoagulants in children[ J]. J Pediatr, 1999,134: 199- 205.
  • 6ORLANDO E, CORTELAZZO S, MARCHETTI M, et al. Prolonged bleeding time in patients with lupus anticoagulant[ J]. Thromb Haemost, 1992,68:495-499.
  • 7LUTTERS BC, DERKSEN RH, TEKELENBURG WL, et al. Dimers of β2- glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2 [J]. J Biol Chem, 2003,278:33831-33838.
  • 8OOSTING JD, DERKSEN RH, BLOKZIJL L, et al. Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity-studies in a thrombosis model[ J]. Thromb Haemost, 1992,68: 278- 284.
  • 9URBANUS RT, DE LAAT HB, DE GROOT PG, et al. Prolongation bleeding time and lupus anticoagualnt: a second paradox in the antiphospholipid syndrome[J ]. Arthritis & Rheumatism, 2004,50: 3605- 3609.

同被引文献46

  • 1Rapaport SI, Ames SB, Duvall BJ. A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with anti-prothrombinase activity [J]. Blood, 1960,15(2): 212-227.
  • 2Gonyea L, Herdman R, Bridges RA. The coagula- tion abnormalities in systemic lupus erythematosus [J]. Thromb Diath Haemorrh,1968, 20(3): 457-464.
  • 3Corrigan JJ Jr, Patterson JH, May NE. Incoagulability of the blood in systemic lupus erythematosus. A case due to hypoprothrombinemia and a circulating anticoagulant [J]. Am J Dis Child, 1970, 119(4): 365-369.
  • 4Bajaj SP, Rapaport SI, Fierer DS, et al. A mechanism for the hypoprothrombinemia of the acquired hypothrombinemia- lupus anticoagulant syndrome [J]. Blood, 1983, 61(4): 684-692.
  • 5Houbouyan L, Armengaud D, Leroy B, et al. Antipro- thrombinase anticoagulant and acquired prothrombin defi- ciency in childhood viral pathology. Spontaneous recovery [J]. Arch Fr Pediatr, 1984, 41(6).. 417-420[French].
  • 6Bernstein ML, Salusinsky-Sternbach M, Bellefleur M, et aL Thrombotic and hemorrhagic complications in children with the lupus anticoagulant [J]. Am J Dis Child, 1984, 138(12): 1132-1135.
  • 7Jaeger U, Kapiotis S, Pabinger I, et al. Transient lupus antico- agulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection [J]. Ann Hematol, 1993, 67(2): 95-99.
  • 8Bemini JC, Buchanan GR, Ashcraft J. Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant [J]. J Pediatr, 1993, 123(6): 937-939.
  • 9Humphries JE, Transfusion therapy in acquired coagulopathies [J]. Hematol Oncol Clin North Am, 1994, 8(6): 1181-1201.
  • 10Gonzalez CM, Lopez-Longo FJ, Monteagudo I, et al.Antiribonucleoprotein antibodies in children with human immunodeficiency virus infection: comparative study with childhood-onset systemic lupus erythematosus [J]. Pediatr AIDS HIV Infect, 1996, 7(6): 401-408.

引证文献9

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部